recently reported that LLGL2 promoted leucine uptake and conferred tumor growth and resistance to tamoxifen treatment by increasing the cell surface levels of SLC7A5 in Erα-positive breast cancer. This evidence concerns the gene SLC7A5 and neoplasm.